ISRCTN ISRCTN76271778
DOI https://doi.org/10.1186/ISRCTN76271778
Protocol serial number 53k on November 1, 2010
Sponsor E-Piim (Estonia)
Funder E-Piim (Estonia)
Submission date
29/10/2012
Registration date
15/11/2012
Last edited
27/11/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Metabolic syndrome is a combination of diabetes, high blood pressure and obesity, which puts you at greater risk of heart disease, stroke and other conditions affecting the blood vessels. The aim of this study is to assess the effectiveness of a low-calorie diet supplemented with probiotic cheese in adult patients with obesity and high blood pressure.

Who can participate?
Obese people aged 30-69 with high blood pressure.

What does the study involve?
Participants are randomly allocated to one of two groups. One group consumes a low-calorie diet supplemented with 50g per day of probiotic cheese. The other group consumes a low-calorie diet supplemented with 50g per day of regular cheese. The study lasts for 3 weeks, and participants are asked to provide blood, urine and fecal samples to test the effects of the probiotic.

What are the possible benefits and risks of participating?
The study causes minimal inconveniences to participants. As blood samples are taken by an
experienced nurse, the procedure is safe. However, there may be bruising and discomfort
at the site of the blood test as with any blood test. The amounts of blood we are taking are
small enough that they should not make you feel fatigue or cause anemia.

Where is the study run from?
The Clinic of the Institute of Nutrition, Russian Academy of Medical Sciences.

When is the study starting and how long is it expected to run for?
November 2010 to March 2011.

Who is funding the study?
Clinic of the Institute of Nutrition, Russian Academy of Medical Sciences.

Who is the main contact?
Prof Khayder Sharafetdinov
sharafandr@mail.ru

Contact information

Prof Khayder Sharafetdinov
Scientific

2/14 Ustinsky Proezd
Moscow
109240
Russian Federation

Phone +8 (499) 794 3516
Email sharafandr@mail.ru

Study information

Primary study designInterventional
Study designRandomized blinded controlled parallel-designed two-armed intervention trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleStudy of the efficiency of dietary inclusion of a probiotic product containing Lactobacillus plantarum Tensia™ DSM 21380 in obese patients with arterial hypertension
Study objectivesProbiotic cheese comprising L. plantarum TENSIA under the hypocaloric diet improves the host metabolic markers.
Ethics approval(s)Institute of Nutrition Ethics Review Committe, Russian Academy of Medical Sciences, 17 November 2010, ref: 77
Health condition(s) or problem(s) studiedMetabolic syndrome with hypertension
InterventionStandard treatment with hypocaloric diet with 50g of regular cheese for control group.

Standard treatment with hypocaloric diet with 50g/day probiotic cheese for test group.
Intervention typeOther
Primary outcome measure(s)

1. Significant decrease of blood pressure
2. Significant decrease of body mass index (BMI)

Key secondary outcome measure(s)

Colonization of GI tract with L. plantarum Tensia

Completion date31/03/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration40
Key inclusion criteria1. Age 30-69 years
2. Diagnosis of metabolic syndrome characterized by obesity accompanied with arterial hypertonia (>130/85 mm Hg)
3. Absence of decompensated chronic diseases needing intensive treatment
4. Informed consent
Key exclusion criteria1. A history of gastrointestinal disease
2. Food allergy and acute infection
3. Use of any antimicrobial agent within the preceeding month
4. Pregnancy and breastfeeding
5. No wish to participate
Date of first enrolment01/11/2010
Date of final enrolment31/03/2011

Locations

Countries of recruitment

  • Russian Federation

Study participating centre

2/14 Ustinsky Proezd
Moscow
109240
Russian Federation

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 12/10/2013 Yes No
Protocol article protocol 01/08/2012 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes